Why Pfizer, BioNTech, and Moderna Shot Higher Today
_0.png?locale=de){kind=logo}
Three of the top coronavirus stocks, Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX), and Moderna (NASDAQ: MRNA), saw plenty of action on the market Thursday. Encouraging news for Pfizer and BioNTech's Comirnaty coronavirus vaccine pushed the share prices of those two companies slightly higher on the day, by a respective 1.4% and 6.7%, with fellow jab maker Moderna cruising along for the ride with a 1.5% gain.
A report published Thursday morning in The New York Times stated that the Food and Drug Administration (FDA) plans to authorize booster shots of Pfizer and BioNTech's vaccine for people aged 12 to 15. Citing "people familiar with the agency's deliberations," the newspaper said the FDA also aims to authorize a booster for younger children (aged 5 to 11) burdened with immune deficiencies.
Image source: Getty Images.
Source Fool.com
